BRIEF published on 12/18/2024 at 07:35, 3 days 11 hours ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 3 days 11 hours ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 month 15 days ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 1 month 15 days ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 3 months 1 day ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 3 months 1 day ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 3 months 3 days ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
PRESS RELEASE published on 09/18/2024 at 07:30, 3 months 3 days ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
BRIEF published on 09/12/2024 at 07:35, 3 months 9 days ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
PRESS RELEASE published on 09/12/2024 at 07:30, 3 months 9 days ago Inside Information / Other news releases Sensorion announces participation in the 59th Annual Inner Ear Biology Workshop in Warsaw, Poland. Presentation on SENS-401 and gene therapy programs Gene Therapy Sensorion Hearing Loss SENS-401 Inner Ear Biology Workshop
Published on 12/21/2024 at 01:30, 17 hours 36 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 36 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 1 minute ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 19 hours 36 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 15 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 21 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 56 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 6 hours 49 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago Share capital decrease by way of treasury shares cancellation
